Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials

Norrby, Mari; Vesikari, Timo; Lindqvist, Lars; Maeurer, Markus; Ahmed, Raija; Mahdavifar, Shahnaz; Bennett, Sean; McLain, J Bruce; Shepherd, Barbara M; Li, Laner; Hokey, David A; Kromann, Ingrid; Hoff, Søren T; Anderssen, Peter; de Wisser, Andriëtte W; Joosten, Simone A; Ottenhoff, Tom H; Andersson, Jan; Brighenti, Susanna (2017)
 
Avaa tiedosto
Lataukset: 



Norrby, Mari
Vesikari, Timo
Lindqvist, Lars
Maeurer, Markus
Ahmed, Raija
Mahdavifar, Shahnaz
Bennett, Sean
McLain, J Bruce
Shepherd, Barbara M
Li, Laner
Hokey, David A
Kromann, Ingrid
Hoff, Søren T
Anderssen, Peter
de Wisser, Andriëtte W
Joosten, Simone A
Ottenhoff, Tom H
Andersson, Jan
Brighenti, Susanna
2017

Vaccine 35 12
1652-1661
Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences
doi:10.1016/j.vaccine.2017.01.055
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:uta-201704111432
Kokoelmat